Nonalcoholic Fatty Liver Disease and the Gut-Liver Axis: Exploring an Undernutrition Perspective

被引:52
|
作者
Bauer, Kylynda C. [1 ,2 ,3 ]
Littlejohn, Paula T. [1 ,2 ]
Ayala, Victoria [4 ,5 ]
Creus-Cuadros, Anna [1 ]
Finlay, B. Brett [1 ,2 ,6 ]
机构
[1] Univ British Columbia, Michael Smith Labs, Vancouver, BC, Canada
[2] Univ British Columbia, Dept Microbiol & Immunol, 2185 East Mall, Vancouver, BC V6T 1Z4, Canada
[3] NCI, Thorac & Gastrointestinal Malignancies Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
[4] Inst Recerca Biomed Lleida IRB Lleida, Lleida, Spain
[5] Univ Lleida, Dept Expt Med, Lleida, Spain
[6] Univ British Columbia, Biochem & Mol Biol Dept, Vancouver, BC, Canada
基金
加拿大健康研究院;
关键词
Gut Microbiome; NAFLD; Gut-Liver Axis; Malnutrition; Undernutrition; SELENIUM CO-SUPPLEMENTATION; HEPATIC GLUCOSE-METABOLISM; OXIDATIVE STRESS; VITAMIN-E; INTESTINAL PERMEABILITY; CHILD UNDERNUTRITION; BILE-ACIDS; MICROBIOTA; ZINC; COPPER;
D O I
10.1053/j.gastro.2022.01.058
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Nonalcoholic fatty liver disease (NAFLD) is a chronic condition affecting one quarter of the global population. Although primarily linked to obesity and metabolic syndrome, undernutrition and the altered (dysbiotic) gut microbiome influence NAFLD progression. Both undernutrition and NAFLD prevalence are predicted to considerably increase, but how the undernourished gut microbiome contributes to hepatic pathophysiology remains far less studied. Here, we present undernutrition conditions with fatty liver features, including kwashiorkor and micronutrient deficiency. We then review the gut microbiota-liver axis, highlighting key pathways linked to NAFLD progression within both overnutrition and undernutrition. To conclude, we identify challenges and collaborative possibilities of emerging multiomic research addressing the pathology and treatment of undernourished NAFLD.
引用
收藏
页码:1858 / +
页数:20
相关论文
共 50 条
  • [1] Bile Acid Receptors and the Gut-Liver Axis in Nonalcoholic Fatty Liver Disease
    Xue, Rui
    Su, Lianyong
    Lai, Shengyi
    Wang, Yanyan
    Zhao, Derrick
    Fan, Jiangao
    Chen, Weidong
    Hylemon, Phillip B.
    Zhou, Huiping
    [J]. CELLS, 2021, 10 (11)
  • [2] The gut-liver axis in nonalcoholic fatty liver disease: molecular mechanisms and new targets
    Schneider, Kai Markus
    Trautwein, Christian
    [J]. GASTROENTEROLOGE, 2020, 15 (02): : 112 - 122
  • [3] The Gut-Liver Axis in Nonalcoholic Fatty Liver Disease: Another Pathway to Insulin Resistance?
    Vanni, Ester
    Bugianesi, Elisabetta
    [J]. HEPATOLOGY, 2009, 49 (06) : 1790 - 1792
  • [4] Gut-liver axis and fibrosis in nonalcoholic fatty liver disease: An input for novel therapies
    Frasinariu, Otilia E.
    Ceccarelli, Sara
    Alisi, Anna
    Moraru, Evelina
    Nobili, Valerio
    [J]. DIGESTIVE AND LIVER DISEASE, 2013, 45 (07) : 543 - 551
  • [5] Gut-liver axis modulation of Panax notoginseng saponins in nonalcoholic fatty liver disease
    Yu Xu
    Ning Wang
    Hor-Yue Tan
    Sha Li
    Cheng Zhang
    Yibin Feng
    [J]. HEPATOLOGY INTERNATIONAL, 2021, 15 (02) : 350 - 365
  • [6] Gut-liver axis in the progression of nonalcoholic fatty liver disease: From the microbial derivatives-centered perspective
    Luo, Lijun
    Chang, Yongchun
    Sheng, Li
    [J]. LIFE SCIENCES, 2023, 321
  • [7] Intestinal dysbiosis in nonalcoholic fatty liver disease (NAFLD): focusing on the gut-liver axis
    Han, Hui
    Jiang, Yi
    Wang, Mengyu
    Melaku, Mebratu
    Liu, Lei
    Zhao, Yong
    Everaert, Nadia
    Yi, Bao
    Zhang, Hongfu
    [J]. CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION, 2023, 63 (12) : 1689 - 1706
  • [8] Gut-liver axis modulation of Panax notoginseng saponins in nonalcoholic fatty liver disease
    Yu Xu
    Ning Wang
    Hor-Yue Tan
    Sha Li
    Cheng Zhang
    Yibin Feng
    [J]. Hepatology International, 2021, 15 : 350 - 365
  • [9] The Gut-Liver Axis in Chronic Liver Disease: A Macrophage Perspective
    De Muynck, Kevin
    Vanderborght, Bart
    Van Vlierberghe, Hans
    Devisscher, Lindsey
    [J]. CELLS, 2021, 10 (11)
  • [10] Bacterial and eukaryotic extracellular vesicles and nonalcoholic fatty liver disease: new players in the gut-liver axis?
    Villard, Alexandre
    Boursier, Jerome
    Andriantsitohaina, Ramaroson
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2021, 320 (04): : G485 - G495